LIFE SPINE® ANNOUNCES FDA CLEARANCE OF PROLIFT® EXPANDABLE INTERBODY SYSTEM
Huntley, IL, March 8, 2016 –
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the PROLIFT Expandable Interbody System.
PROLIFT is the latest addition to the company’s best in class, patented platform of expandable interbody technologies. The all titanium system restores disc height, in-situ, for minimally invasive PLIF, TLIF and oblique approaches.
“The PROLIFT Expandable Interbody System allows for simplified, contracted insertion with minimal anatomical disruption and retraction. Once implanted, it can expand cephalad to caudal to accommodate disc height ranges from 8mm to 16mm for varying patient anatomy. When paired with the CENTERLINETM Midline Thoracolumbar Screw System, PROLIFT creates the optimal hyper-minimally invasive solution,” said Rich Mueller, Chief Operating Officer.
PROLIFT is scheduled for limited release in the second quarter of 2016, with full product release expected later in the year.
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms.